AbbVie Submits Supplemental NDA for Vraylar for Adjunctive MDD Therapy - Drug Topics

Submitted by Anonymous (not verified) on Tue, 02/22/2022 - 15:47

AbbVie Submits Supplemental NDA for Vraylar for Adjunctive MDD Therapy  Drug Topics